The time has come to reexamine the gold standard when evaluating noninvasive testing.
Angiographically identified 50% cross-sectional narrowing of a coronary artery fails to accurately identify compromised myocardial perfusion. Noninvasive tests should be correlated with intravascular ultrasound or coronary flow reserve to determine their clinical utility.